Skip to main content

Qureight

Qureight accelerates clinical trial development at key decision points through data curation and AI-powered decision making. They work with pharmaceutical companies, contract research organisations and hospitals to curate data and help the best drugs get approved: so they can be given to patients who need them the most. Qureight are currently focused on lung and heart disease.

Trading name

 Qureight 

Sector

 HeathTech

Founders

Dr Muhunthan Thillai & Dr Alessandro Ruggiero

Date invested

19/03/2024

Date founded04/01/2018
StatusCurrent Investment

 

Image
Qureight Logo